These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2513287)
1. Treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator. Glazier JJ; Crowley J; Cremin D; Coll T; Daly K Ir Med J; 1989 Sep; 82(3):111-4. PubMed ID: 2513287 [TBL] [Abstract][Full Text] [Related]
2. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy. Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974 [TBL] [Abstract][Full Text] [Related]
3. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
4. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction. Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525 [TBL] [Abstract][Full Text] [Related]
5. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator: a new thrombolytic agent. Crabbe SJ; Cloninger CC Clin Pharm; 1987 May; 6(5):373-86. PubMed ID: 3117481 [TBL] [Abstract][Full Text] [Related]
7. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]. Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348 [TBL] [Abstract][Full Text] [Related]
8. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537 [TBL] [Abstract][Full Text] [Related]
9. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy]. Kobusiak-Prokopowicz M; Mysiak A Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704 [TBL] [Abstract][Full Text] [Related]
10. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]
11. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction]. Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927 [TBL] [Abstract][Full Text] [Related]
12. New developments in thrombolytic therapy. Collen D; Gold HK Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261 [TBL] [Abstract][Full Text] [Related]
13. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo]. Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297 [TBL] [Abstract][Full Text] [Related]
14. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [TBL] [Abstract][Full Text] [Related]
16. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group. Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025 [TBL] [Abstract][Full Text] [Related]
17. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction. Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428 [TBL] [Abstract][Full Text] [Related]
18. Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rate. Huber K; Beckmann R; Probst P; Rauscha F; Kaindl F; Binder BR Thromb Haemost; 1993 Jan; 69(1):45-9. PubMed ID: 8446938 [TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue-plasminogen activator (rt-PA) in acute myocardial infarction in the Chinese in Hong Kong. Woo KS; Tse KK; Mak YK; Chung HK; Tse CY Chin Med J (Engl); 1992 May; 105(5):374-8. PubMed ID: 1499366 [TBL] [Abstract][Full Text] [Related]
20. [Earlier treatment of acute myocardial infarction with administration of alteplase (rt-PA) before hospitalization]. Bouten MJ; Simoons ML; Hartman JA; van Miltenburg AJ; van der Does E; Pool J Ned Tijdschr Geneeskd; 1990 Dec; 134(50):2434-8. PubMed ID: 2124655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]